Researchers make big step in HIV cure
Washington. Researchers have successfully eliminated HIV from the DNA of an infected mice, a promising step towards a cure for the nearly 37 million people living with the virus.
In a study published on Tuesday in Nature Communications, researchers from Temple University’s Lewis Katz School of Medicine and the University of Nebraska Medical Centre (UNMC) coupled genome editing technology with a slow-release virus suppression drug to eliminate HIV cells entirely from some infected mice.
Current HIV treatment cannot eliminate the virus entirely but does suppress its replication. Antiretroviral therapy, or ART, requires lifelong use to stall the virus’ spread and, as a May study found, can potentially end the transmission of HIV between sexual partners. Testing their methods on a group of infected “humanised mice,” or rodents engineered to produce human T cells susceptible to HIV, researchers administered a treatment called LASER ART, or long-acting, slow-effective release ART, to suppress HIV cells from replicating.
The team modified the drug for a slow release across several weeks, targeting tissue in the spleen, bone marrow and brain where latent HIV reservoirs, or clusters of inactive HIV cells, were likely to occur.
To eliminate the remaining infective cells from the subject’s DNA, they employed a gene editing tool called CRISPR-Cas9.
The process allowed the teams to “clean segments of the genome” and remove the HIV chromosome, co-author Kamel Khalili told CNN.
By the study’s end, researchers had successfully eliminated the virus from nine out of 23 mice. The results prove that HIV can be eliminated, researchers say.
The two labs initially began their research separately: Howard Gendelman at UNMC pursued trials with LASER ART, while Khalili at Temple University had been tampering with CRISPR technology for five years.
They combined their efforts to attempt complete elimination of the virus. And their lofty goal required a unique approach.
Khalili said he treated HIV as a genetic disease: Once the virus infects a subject, the viral genome enters into the chromosome and becomes a “bad gene,” he said.
Combination therapy was a prime way to attack HIV from both angles: Slow its spread first with LASER ART, then edit it out completely with CRISPR.
To confirm they would eradicated the virus, a process that took years, Gendelman told CNN the team examined every “nook and cranny” of the mice’s tissue where infected cells may lurk.
The results are proof that elimination of HIV is possible—but they’re just a first step, not a leap straight to cure, he cautioned.
